<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/378" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/378</id>
  <updated>2026-04-30T18:35:05Z</updated>
  <dc:date>2026-04-30T18:35:05Z</dc:date>
  <entry>
    <title>Calitatea vieţii la pacienii cu bronhopneumopatie cronică obstructivă</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4892" />
    <author>
      <name>Ţerna, Eudochia</name>
    </author>
    <author>
      <name>Matcovschi, Serghei</name>
    </author>
    <author>
      <name>Borosean, Doina</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4892</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Calitatea vieţii la pacienii cu bronhopneumopatie cronică obstructivă
Authors: Ţerna, Eudochia; Matcovschi, Serghei; Borosean, Doina
Abstract: The aim of this study was to assess the quality of life in COPD patients in different&#xD;
stages of development. The findings confirm that the quality of life is severely affected by the&#xD;
disease in the group of patients with stage the IIIrd COPD. The current severe damage was&#xD;
demonstrated by affecting the total score of the questionnaire St.George 's Respiratory&#xD;
Questionnaire (SGRQ).&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Scopul acestui studiu a fost de a aprecia calitatea vieţii la pacienţii cu BPCO în diferite&#xD;
stadii de evoluţe. Rezultatele studiului au demonstrat că calitatea vieţii legată de sănătate este&#xD;
mai sever afectată de maladie în lotul pacienţilor cu stadiul III de BPCO. Această deteriorare&#xD;
severă a fost demonstrată prin afectarea scorului total a chestionarului St.George’s Respiratory&#xD;
Questionnaire (SGRQ).
Description: Departamentul Medicină Internă, Clinica medicală Nr.1&#xD;
Universitatea de Stat de Medicină şi Farmacie “NicolaeTestemiţeanu”</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Influenţa eficacităţii trimetazidinei în tratamentul complex al bronhopneumopatiei cronice obstructive asociate cu cardiopatia ischemică</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4895" />
    <author>
      <name>Condaruc, Natalia</name>
    </author>
    <author>
      <name>Butorov, Valentina</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4895</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Influenţa eficacităţii trimetazidinei în tratamentul complex al bronhopneumopatiei cronice obstructive asociate cu cardiopatia ischemică
Authors: Condaruc, Natalia; Butorov, Valentina
Abstract: COPD associated with ischemic coronary disease is not only a medical problem, but also a&#xD;
socio-economic one, which tends to affect younger people, physically active. Treatment of&#xD;
associated pathology still remains a current direction in contemporary medicine.&#xD;
The study included 52 patients with II degree of COPD, associated with ischemic coronary&#xD;
disease. The patients were investigated by ECG, Hollter, echocardiography and spirography.&#xD;
Combined treatment with trimetazidine was established to be more efficient versus the&#xD;
comparison group.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
BPCO asociată cu CI reprezintă nu doar o problemă medicală, dar şi social-economică&#xD;
importantă, care tinde să afecteze populaţia tot mai tânără, aptă de muncă, tratamentul patologiei&#xD;
asociate rămânând o direcţie actuală în medicina contemporană.&#xD;
Studiul a inclus 52 pacienti cu BPCO gr.II asociată cu CI cărora li s-a evaluat ECG, ECGHollter,&#xD;
ecocardiografia şi spirografia. S-a stabilit eficacitatea mai pronunţată a tratamentului&#xD;
combinat cu trimetazidină prin ameliorarea indicilor clinici la pacienţii din lotul respectiv versus&#xD;
celui de comparaţie.
Description: Catedra Medicina Internă Nr.3, USMF „N. Testemiţanu”</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Aspectele clinico-farmacologice ale perindoprilului în tratamentul cordului pulmonar cronic</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4894" />
    <author>
      <name>Butorov, Serghei</name>
    </author>
    <author>
      <name>Gonciar, Veaceslav</name>
    </author>
    <author>
      <name>Condaruc, Natalia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4894</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Aspectele clinico-farmacologice ale perindoprilului în tratamentul cordului pulmonar cronic
Authors: Butorov, Serghei; Gonciar, Veaceslav; Condaruc, Natalia
Abstract: The study included 46 patients with COPD complicated with CPH, treated with ACE&#xD;
inhibitor - perindopril associated with basic therapy. It was found that the inclusion of&#xD;
perindopril in the complex treatment of patients with COPD complicated by CPH improves the&#xD;
clinical course of disease, beneficially acting on indices of central and intracardiac&#xD;
hemodynamics and on cardiac arrhythmias.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Studiul a inclus 46 pacienţi cu BPCO complicată cu CPC, cărora li s-a efectuat tratamentul&#xD;
cu inhibitorul ECA – perindopril asociat cu terapia de bază. S-a constatat că includerea&#xD;
perindoprilului în tratamentul complex al pacienţilor cu BPCO complicat cu CPC ameliorează&#xD;
evoluţia clinică a maladiei, acţionează benefic asupra indicilor hemodinamicii centrale şi&#xD;
intracardiace, şi asupra tulburărilor de ritm cardiac.
Description: Catedra Farmacologie şi Farmacie Clinică, USMF „N. Testemiţanu”&#xD;
Catedra Medicina Internă</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Eficacitatea activităţii de reabilitare în optimizarea tratamentului de recuperare al pacienţilor cu bronhopneumopatie cronică obstructivă</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/4893" />
    <author>
      <name>Butorov, Ivan</name>
    </author>
    <author>
      <name>Arama, Maria</name>
    </author>
    <author>
      <name>Butorov, Serghei</name>
    </author>
    <author>
      <name>Condaruc, Natalia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/4893</id>
    <updated>2019-06-25T21:51:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Eficacitatea activităţii de reabilitare în optimizarea tratamentului de recuperare al pacienţilor cu bronhopneumopatie cronică obstructivă
Authors: Butorov, Ivan; Arama, Maria; Butorov, Serghei; Condaruc, Natalia
Abstract: The study included 36 patients with moderate degree of COPD, with a stable evolution. A&#xD;
program of physical and complementary therapy was elaborated as a recovery treatment. It was&#xD;
established a significant clinico-functional effect, manifested by reduced bronchial obstruction&#xD;
syndrome and improvement of the quality of life.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Au fost examinaţi 36 pacienţi cu BPCO de gravitate medie cu evoluţie stabilă. S-a elaborat&#xD;
un program complex de terapie fizică şi complementară pentru tratamentul de recuperare. S-a&#xD;
stabilit un efect clinico-funcţional semnificativ, care s-a manifestat prin diminuarea gravităţii&#xD;
sindromului bronhoobstructiv şi ameliorarea calităţii vieţii.
Description: Departamentul Medicina Internă. Catedra Boli ocupaţionale, USMF “N. Testemiţanu”</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

